Author
Listed:
- Prasenjit Prasad Saha
(Cleveland Clinic
Cleveland Clinic)
- Valentin Gogonea
(Cleveland Clinic
Cleveland Clinic
Cleveland State University)
- Wendy Sweet
(Cleveland Clinic)
- Maradumane L. Mohan
(Cleveland Clinic)
- Khuraijam Dhanachandra Singh
(Cleveland Clinic)
- James T. Anderson
(Cleveland Clinic
Cleveland Clinic)
- Deepthi Mallela
(Cleveland Clinic
Cleveland Clinic)
- Conner Witherow
(Cleveland Clinic)
- Niladri Kar
(Cleveland Clinic)
- Kate Stenson
(Cleveland Clinic)
- Terri Harford
(Cleveland Clinic)
- Michael A. Fischbach
(Stanford University)
- J. Mark Brown
(Cleveland Clinic
Cleveland Clinic)
- Sadashiva S. Karnik
(Cleveland Clinic)
- Christine S. Moravec
(Cleveland Clinic)
- Joseph A. DiDonato
(Cleveland Clinic
Cleveland Clinic)
- Sathyamangla Venkata Naga Prasad
(Cleveland Clinic)
- Stanley L. Hazen
(Cleveland Clinic
Cleveland Clinic
Cleveland Clinic)
Abstract
Allosteric modulation is a central mechanism for metabolic regulation but has yet to be described for a gut microbiota-host interaction. Phenylacetylglutamine (PAGln), a gut microbiota-derived metabolite, has previously been clinically associated with and mechanistically linked to cardiovascular disease (CVD) and heart failure (HF). Here, using cells expressing β1- versus β2-adrenergic receptors (β1AR and β2AR), PAGln is shown to act as a negative allosteric modulator (NAM) of β2AR, but not β1AR. In functional studies, PAGln is further shown to promote NAM effects in both isolated male mouse cardiomyocytes and failing human heart left ventricle muscle (contracting trabeculae). Finally, using in silico docking studies coupled with site-directed mutagenesis and functional analyses, we identified sites on β2AR (residues E122 and V206) that when mutated still confer responsiveness to canonical β2AR agonists but no longer show PAGln-elicited NAM activity. The present studies reveal the gut microbiota-obligate metabolite PAGln as an endogenous NAM of a host GPCR.
Suggested Citation
Prasenjit Prasad Saha & Valentin Gogonea & Wendy Sweet & Maradumane L. Mohan & Khuraijam Dhanachandra Singh & James T. Anderson & Deepthi Mallela & Conner Witherow & Niladri Kar & Kate Stenson & Terri, 2024.
"Gut microbe-generated phenylacetylglutamine is an endogenous allosteric modulator of β2-adrenergic receptors,"
Nature Communications, Nature, vol. 15(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-50855-3
DOI: 10.1038/s41467-024-50855-3
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-50855-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.